Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation
Kavisha Arora(Cedars-Sinai Medical Center), Anjaparavanda P. Naren(Cedars-Sinai Medical Center)
American Journal of Physiology-Lung Cellular and Molecular Physiology
June 4, 2016
Cited by 15
Related Papers
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
CFTR modulator theratyping: Current status, gaps and future directions
|Journal of Cystic Fibrosis|2018|288
Catalytic region mimetics in Na+/H+ exchanger regulatory factor 4 suppress guanylate cyclase 2C activity to regulate enterotoxin triggered diarrhea
|Journal of Biological Chemistry|2025|1